Loading organizations...
§ Private Profile · Zürich, Zurich, Switzerland
Develops medical-grade wearable devices for continuous vital sign monitoring, supporting remote patient monitoring and clinical trials.
Biovotion is a Zurich, Switzerland-based medical technology company that develops clinical-grade wearable devices for continuous vital sign monitoring and remote patient care. The organization provides hardware and software solutions, including its flagship Everion armband, to healthcare systems, clinical research organizations, and pharmaceutical companies for chronic disease management. Prior to its eventual acquisition, the enterprise raised approximately $14 million in venture funding and secured a notable industry endorsement from the XPrize Foundation. In November 2019, the business and its portfolio of over 60 clinical patents were acquired by Boston-based digital therapeutics firm Biofourmis, led by chief executive officer Kuldeep Singh Rajput. Following the transaction, the company's physiological data collection technology was integrated into the acquiring firm's predictive analytics ecosystem to support personalized medical interventions. Biovotion was originally founded in 2011 by entrepreneur Andreas Caduff.
Biovotion has raised $10.3M across 1 funding round.
Biovotion has raised $10.3M in total across 1 funding round.
Biovotion has raised $10.3M in total across 1 funding round.
Biovotion's investors include Swiss Re, STMicroelectronics.
Biovotion has raised $10.3M across 1 funding round. Most recently, it raised $10.3M Series A in June 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 7, 2016 | $10.3M Series A | Swiss RE | STMicroelectronics | Announced |